Cargando…
Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
Autores principales: | Joob, Beuy, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262883/ https://www.ncbi.nlm.nih.gov/pubmed/25538496 http://dx.doi.org/10.4103/1450-1147.144825 |
Ejemplares similares
-
Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience
por: Rasulova, Nigora, et al.
Publicado: (2013) -
Leishmaniasis: Bone Marrow Aspirate Smear and Rapid Antibody Test
por: Joob, Beuy, et al.
Publicado: (2017) -
Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease
por: Rasulova, Nigora, et al.
Publicado: (2013) -
Rapid decreasing of transfused platelet in a cancerous patient: Anti-platelet antibody
por: Joob, Beuy, et al.
Publicado: (2012) -
Anti-smooth Muscle Antibodies and Liver Enzymes in Differentiation of Extrahepatic Biliary Atresia and Idiopathic Neonatal Hepatitis: Concern in Laboratory Medicine View
por: Joob, Beuy, et al.
Publicado: (2017)